InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Lilly (Eli)

LLY Clue Score73
United States Fiscal year ends December CIK 0000059478
$1,179.27 +0.83% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1,179.27 +404.67% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueNet income
Fiscal year 2016Revenue21.22Net income2.74EPS, diluted2.58Fiscal year 2017Revenue19.97 −5.9%Net income−0.20 −107.5%EPS, diluted−0.19 −107.4%Fiscal year 2018Revenue21.49 +7.6%Net income3.23EPS, diluted3.13Fiscal year 2019Revenue22.32 +3.8%Net income8.32 +157.4%EPS, diluted8.89 +184.0%Fiscal year 2020Revenue24.54 +9.9%Net income6.19 −25.5%EPS, diluted6.79 −23.6%Fiscal year 2021Revenue28.32 +15.4%Net income5.58 −9.9%EPS, diluted6.12 −9.9%Fiscal year 2022Revenue28.54 +0.8%Net income6.24 +11.9%EPS, diluted6.90 +12.7%Fiscal year 2023Revenue34.12 +19.6%Net income5.24 −16.1%EPS, diluted5.80 −15.9%Fiscal year 2024Revenue45.04 +32.0%Net income10.59 +102.1%EPS, diluted11.71 +101.9%Fiscal year 2025Revenue65.18 +44.7%Net income20.64 +94.9%EPS, diluted22.95 +96.0%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 21.22 19.97 21.49 22.32 24.54 28.32 28.54 34.12 45.04 65.18
Growth −5.9% +7.6% +3.8% +9.9% +15.4% +0.8% +19.6% +32.0% +44.7%
Net income 2.74 −0.20 3.23 8.32 6.19 5.58 6.24 5.24 10.59 20.64
Growth −107.5% +157.4% −25.5% −9.9% +11.9% −16.1% +102.1% +94.9%
EPS, diluted 2.58 −0.19 3.13 8.89 6.79 6.12 6.90 5.80 11.71 22.95
Growth −107.4% +184.0% −23.6% −9.9% +12.7% −15.9% +101.9% +96.0%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Net margin
Fiscal year 2016Net margin12.9%Fiscal year 2017Net margin−1.0%Fiscal year 2018Net margin15.0%Fiscal year 2019Net margin37.3%Fiscal year 2020Net margin25.2%Fiscal year 2021Net margin19.7%Fiscal year 2022Net margin21.9%Fiscal year 2023Net margin15.4%Fiscal year 2024Net margin23.5%Fiscal year 2025Net margin31.7%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net margin 12.9% −1.0% 15.0% 37.3% 25.2% 19.7% 21.9% 15.4% 23.5% 31.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2016Operating cash flow4.85Buybacks−0.60Dividends paid−2.16Fiscal year 2017Operating cash flow5.62Buybacks−0.30Dividends paid−2.19Fiscal year 2018Operating cash flow5.52Buybacks−4.15Dividends paid−2.31Fiscal year 2019Operating cash flow4.84Buybacks−4.40Dividends paid−2.41Fiscal year 2020Operating cash flow6.50Buybacks−0.50Dividends paid−2.69Fiscal year 2021Operating cash flow7.37Buybacks−1.25Dividends paid−3.09Fiscal year 2022Operating cash flow7.59Buybacks−1.50Dividends paid−3.54Fiscal year 2023Operating cash flow4.24Buybacks−0.75Dividends paid−4.07Fiscal year 2024Operating cash flow8.82Buybacks−2.50Dividends paid−4.68Fiscal year 2025Operating cash flow16.81Buybacks−4.11Dividends paid−5.38
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 4.85 5.62 5.52 4.84 6.50 7.37 7.59 4.24 8.82 16.81
Buybacks −0.60 −0.30 −4.15 −4.40 −0.50 −1.25 −1.50 −0.75 −2.50 −4.11
Dividends paid −2.16 −2.19 −2.31 −2.41 −2.69 −3.09 −3.54 −4.07 −4.68 −5.38

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash4.58Total debt8.37Net cash (debt)−3.79Shareholders’ equity14.01Debt to equity0.60Fiscal year 2017Cash6.54Total debt9.94Net cash (debt)−3.40Shareholders’ equity11.59Debt to equity0.86Fiscal year 2018Cash7.32Total debt9.20Net cash (debt)−1.88Shareholders’ equity9.83Debt to equity0.94Fiscal year 2019Cash2.34Total debt13.82Net cash (debt)−11.48Shareholders’ equity2.61Debt to equity5.30Fiscal year 2020Cash3.66Total debt16.59Net cash (debt)−12.93Shareholders’ equity5.64Debt to equity2.94Fiscal year 2021Cash3.82Total debt15.35Net cash (debt)−11.53Shareholders’ equity8.98Debt to equity1.71Fiscal year 2022Cash2.07Total debt14.74Net cash (debt)−12.67Shareholders’ equity10.65Debt to equity1.38Fiscal year 2023Cash2.82Total debt18.32Net cash (debt)−15.50Shareholders’ equity10.77Debt to equity1.70Fiscal year 2024Cash3.27Total debt28.53Net cash (debt)−25.26Shareholders’ equity14.27Debt to equity2.00Fiscal year 2025Cash7.27Total debt40.87Net cash (debt)−33.60Shareholders’ equity26.54Debt to equity1.54
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 4.58 6.54 7.32 2.34 3.66 3.82 2.07 2.82 3.27 7.27
Total debt 8.37 9.94 9.20 13.82 16.59 15.35 14.74 18.32 28.53 40.87
Net cash (debt) −3.79 −3.40 −1.88 −11.48 −12.93 −11.53 −12.67 −15.50 −25.26 −33.60
Shareholders’ equity 14.01 11.59 9.83 2.61 5.64 8.98 10.65 10.77 14.27 26.54
Debt to equity 0.60 0.86 0.94 5.30 2.94 1.71 1.38 1.70 2.00 1.54

In billions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In billions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
21.22 19.97 21.49 22.32 24.54 28.32 28.54 34.12 45.04 65.18
Growth −5.9% +7.6% +3.8% +9.9% +15.4% +0.8% +19.6% +32.0% +44.7%
5.71 4.45 4.68 4.72 5.48 7.31 6.63 7.08 8.42 11.05
5.31 5.10 5.05 5.60 5.98 6.93 7.19 n/a n/a n/a
6.53 5.98 5.98 6.21 6.12 6.43 6.44 7.40 8.59 11.09
3.37 2.30 3.68 5.27 7.23 6.16 6.81 6.55 12.68 25.73
0.64 2.39 0.53 0.63 1.04 0.57 0.56 1.31 2.09 5.09
2.74 −0.20 3.23 8.32 6.19 5.58 6.24 5.24 10.59 20.64
Growth −107.5% +157.4% −25.5% −9.9% +11.9% −16.1% +102.1% +94.9%
Per share
2.59 −0.19 3.14 8.93 6.82 6.15 6.93 5.82 11.76 23.00
2.58 −0.19 3.13 8.89 6.79 6.12 6.90 5.80 11.71 22.95
Growth −107.4% +184.0% −23.6% −9.9% +12.7% −15.9% +101.9% +96.0%
1,058 1,052 1,028 931.1 907.6 907.0 901.7 900.2 900.6 897.3
1,062 1,052 1,034 935.7 912.5 911.7 904.6 903.3 904.1 899.3
Growth −0.9% −1.7% −9.5% −2.5% −0.1% −0.8% −0.1% +0.1% −0.5%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 21.6% a year over five years, and earnings per share grew 27.6% a year.
  • The diluted share count fell 1.4% in five years, so buybacks did some of the work per share.
  • A net loss in 1 of 10 years on file.